Table 2.
Potential Biomarker |
Gene Names | Summary of Evidence | Proteomic Techniques Used | Known Biochemical Function | Limitations | Panels |
---|---|---|---|---|---|---|
Serum Amyloid A
(SAA) |
SAA1 |
Inconsistent evidence Upregulated in EC in some studies [60,61]. No difference between cases and controls in others [62,63]. |
Isobaric tags for relative and absolute quantification (iTRAQ) technology and 2-dimensional liquid chromatography coupled to tandem mass spectrometry (LC–MS/MS). Particle-enhanced immunonephelometry and LS–MS/MS. |
High density lipoprotein. Modulates inflammation. Metabolism and transport of cholesterol. Acute phase reactant |
Lacks selectivity as also elevated in lung, colon and other cancers | SAA+HE4 had 73.3% sensitivity and 64% specificity [62] |
Prolactin
(PRL) |
PRL |
Consistent but limited evidence Sensitivity of 98.3% and specificity of 98% [57]. Upregulated in EC with 16.3% sensitivity and 100.0% specificity at PRL >30 ng/mil [64]. |
Multiplex xMAP™ bead-based immunoassay Electrochemoluminescence immunoassay |
Single-chain protein closely related to GH Secretion by stromal cells in response to tumour growth and differentiation Cytokine with immune and inflammatory functions. |
Elevated in ovarian, pancreatic and lung cancers. | Prolactin, GH, TSH, eotaxin and E-selectin had better accuracy [57] |
Human Epididymis Protein 4
(HE4) |
WFDC2 |
Consistent (evidence from meta-analysis) Sensitivity and specificity of 0.65 (95% CI 0.56–0.73) and 0.9 (95% CI (0.8–0.95) respectively [55]. |
Enzyme immunoassay, Microparticle immunoassay Electrochemiluminescence | A member of the Whey acidic protein family, located on chromosome 20q 12–13 and acts as a proteinase inhibitor (trypsin inhibitor properties). Possible role in sperm maturation | Expressed in ovarian, renal, lung, colon and breast cancers Suboptimal sensitivity Methodological heterogeneity across studies. |
HE4+CA125 57–76% sensitivity and 90–100% specificity [65,66,67,68] |
Alpha-1-beta-gylycoprotein
(AIBG) |
AIBG |
Limited evidence Upregulated in EC [69] |
2-Dimensional gel electrophoresis | Plasma glycoprotein encoded by A1BG gene with unknown function. | Limited evidence Few studies, obsolete technique |
None |
Complement factors
(C3, C4A, C4B) |
C3, C4A, C4B |
Limited evidence Upregulated in EC [70] |
LC–ESI–QTOF(MS1) | Complement proteins involved in immunity and tolerance. | Limited evidence Few studies, small sample size High abundance proteins with low specificity for EC. |
None |
Cancer Antigens
CA125 CA72.4, CA15-3 |
MUC 16
TAG-72 MUC 1 |
Consistent evidence CA125 (MUC 16) sensitivity of 17.8–52.6% and specificity of 33.35% to 95% [37]. |
Enzyme-linked immunosorbent assay (ELISA) Electrochemiluminescence Multiplex bead-based immunoassay |
Mucin family glycoprotein, a component of the female reproductive tract, respiratory and ocular surfaces. | Sub-optimal diagnostic accuracy. Elevated in several other malignancies such as ovarian and pancreatic cancers. |
See above |
Apolipoproteins (A-IV), C1 |
APOA1-4
APOC1 |
Limited and inconsistent evidence Apo A-IV Downregulated in EC [60,70,71]. AI showed SEN 78% and SPE 90%. Apo C1 Upregulated (SEN 82%, SPE 86%) [71]. |
LC–ESI–QTOF (MS1)/SELDI TOF (MSI) SELDI TOF (MSI) |
Lipid transport proteins, stabilise lipoprotein structure and act as enzyme cofactors. | Sub-optimal diagnostic accuracy. High abundance blood proteins with low specificity for EC. |
ApoA-1+TTR+TF 71% SEN, 88% SPE [72] |
Clusterin
(CLU) |
CLU |
Limited Upregulated in EC [69] |
2 DE Electrophoresis | Also known as Apolipoprotein J, Chaperone with anti-apoptotic properties, involved in preventing the aggregation of non-native protein | Limited evidence. Involved in many conditions related to oxidative stress such as ageing, cancers, neuro- degenerative diseases. |
None |
Antithrombin III
(SERPINC I) |
SERPINC 1 |
Limited Upregulated in EC [69] |
2 DE Electrophoresis | Glycoprotein produced by the liver, involved in the coagulation system. May inhibit angiogenesis. | Limited evidence, low specificity for EC. | None |
Alpha 1 antitrypsin
(SERPINA1) |
SERPINA1 |
Limited Downregulated in EC [69] |
2 DE Electrophoresis | A serine protease inhibitor, inhibits enzymes such as trypsin and neutrophil elastase, produced in the liver and transported to the lungs | Limited evidence, low specificity for EC. | None |
Human chitinase-3 like protein1 (YKL-40) | CHI3L1 |
Consistent, limited Upregulated in EC, 76% sensitivity, 89% specificity [73,74]. |
Enzyme-linked immunosorbent assay (ELISA) | Glycoprotein of the chitinase family, involved in degradation of extracellular matrix. | Nonspecific. Elevated in colorectal, breast, leukaemia, lung, melanoma cancers, rheumatoid arthritis etc. | None |
Dickkopf-related protein 3 precursor
(DKK3) |
DKK3 |
Limited, inconsistent Upregulated in EC [75] No difference between cases and controls [74] |
Enzyme-linked immunosorbent assay (ELISA) | Member of the Wnt signalling pathway important in cell division, formation and cell death during embryogenesis. Reported pro-angiogenic effect in tumour growth. | Limited and inconsistent evidence. Implicated in bone disease, cancer and Alzheimers’ disese. |
None |
Visfatin
(NAMPT) |
NAMPT |
Limited Upregulated in EC, 14.9± 10.6 ng/mL and 8.1± 6,9 ng/mL in EC vs. controls respectively (p:0.011) [76] |
Enzyme-linked immunosorbent assay (ELISA) | Secreted by visceral fat, mimics insulin. Possible involvement in metabolic pathways, immune response and cancers. | Limited evidence, may be surrogate for EC risk factors. | None |
VEGFA, VEGFVEGFC | PDGFC |
Limited, Inconsistent Upregulated in EC [77,78] in some studies, Down regulated in EC [57] in others. |
Enzyme-linked immunosorbent assay (ELISA) | Endothelial cell growth factor involved in physiological and pathological angiogenesis. | Limited and inconsistent evidence, non-specific, elevated in many physiological and pathological states. | None |
TSH, ACTH, FSH | CGA, POMC, CGA |
Limited TSH and ACTH upregulated in EC while FSH is downregulated [57] |
Enzyme-linked immunosorbent assay (ELISA), multiplex bead based immunoassay. | TSH and ACTH: communication between immune cells and regulation. FSH: Glycoprotein regulating growth and reproductive processes. |
Limited evidence, all non-specific. | Prolactin, GH, TSH, eotaxin and E-selectin had better accuracy [57] |
ICAM1/CD54 | ICAM 1 |
Limited Upregulated in EC [79] |
Flow cytometry | Leucocyte-endothelial transmigration | Limited evidence | None |
Interleukin s/receptors
(IL31, 33, IL2R) |
IL31, IL33,
IL2R |
Limited Upregulated in EC [57] |
Enzyme-linked immunosorbent assay (ELISA), multiplex bead based immunoassay. | Protein expressed on the surface of immune cells and response to cytokines. | Limited evidence | None |
Cyclophilin A
(CypA) |
PPIA |
Limited Upregulated in EC [80,81] |
Two-dimensional gel electrophoresis and MALDI-Q-TOF MS/MS | Ubiquitous protein, ubiquitous protein, regulates protein folding and trafficking. Plays role in malignant transformation. | Limited evidence, non-specific, high abundance protein, increases with aging and pro-inflammatory conditions such sepsis. | None |
Sperm associated antigen-9 | SPAG9 |
Limited Upregulated in EC vs. controls: 18.3 (12.7–53.8) vs. 14.1(4.3–65.3); SEN 70.4% & SPE 82.5% at SPAG9 > 17 ng/mL [82] |
Enzyme-linked immunosorbent assay (ELISA). | Scaffold protein involved in signalling pathways, Expressed in testicular haploid germ cells, implicated in infertility. | Limited evidence, non-specific, elevated in cervical, bladder and lung cancers. | None |
Growth-regulated oncogene alpha (CXCL1) | CXCL1 |
Limited Upregulated in EC vs. controls (145(70–270)/90(45–237), p < 0.001. AUC = 0.80 [83] |
Immunoassay | Chemokine involved in inflammation and tumorigenesis. | Non-specific, elevated in colorectal, melanoma, gastric cancer, ovarian cancer etc. | None |
Growth differentiation factor 15 (GDF-15) | GDF15 |
Limited Upregulated in EC vs. controls. AUC 0.86 [84] |
Immunoradiometric sandwich assay with polyclonal goat antihuman GDF-15 antibodies. | A transforming growth factor involved in tissue differentiation and maintenance. | Nonspecific, elevated in ovarian thyroid, pancreatic and colon cancers | None |
Adiponectin, Leptin |
ADIPOQ
LEP |
Consistent Adiponectin: Downregulated in EC vs. control (mean g/mL 11.3 vs. 17.2 (p < 0.0001) [85] Leptin: Upregulated in EC vs. control, mean ng/mL (19.5 vs. 13.4, p = 0.03) [85] |
Enzyme-linked immunosorbent assay (ELISA) and RIA | Adipokines with metabolic, inflammatory and immune functions. Leptin is pro-inflammatory and adiponectin is anti-inflammatory. | Markers of obesity and metabolic syndrome. Non-specific. | None |
FAS
(APO1, CD95) |
FAS |
Limited Upregulated in EC [86]. |
Enzyme-linked immunosorbent assay (ELISA) and RIA | Fas-Fas ligand system important in CTL and NK mediated apoptosis. | Limited evidence | None |
Leucine-rich glycoprotein
(LRG1) |
LRG1 |
Limited Upregulated in EC vs. controls [69]. |
2 DE Electrophoresis | Involved in protein-protein interaction signal transduction, cell adhesion and neovascularization. | Limited evidence, non-specific. | None |
Matrix metalloproteinase 2,7,9 |
MMP2
MMP7 MMP9 |
Inconsistent, limited MMP7 upregulated in EC, MMP2 and MMP9 downregulated [87]. |
Enzyme-linked immunosorbent assay (ELISA), multiplex bead based immunoassay. | Enzymes involved in the degradation of extracellular matrix proteins during organogenesis, growth and tissue turnover. | Limited evidence | None |
Transthyretin
(TTR)/Transferin (TF) |
TTR
TF |
Limited evidence Upregulated in EC [88] |
Immunoassay | TTR: Transport protein that carries thyroid hormone and retinol-binding protein.TF: Iron-binding glycoprotein | Limited evidence, non-specific, associated with amyloidosis, cardiomyopathy etc. |
TTR+TF+ ApoA:71%SEN &88% SPE |
Inter-alpha-trypsin inhibitor family heavy chain-related protein (HRP) | ITIH4 |
Limited evidence Upregulated in EC [69] |
2 DE Electrophoresis LC-ESI-QTOF (MS1) |
Plasma glycoprotein, Serine protease inhibitors. | Limited evidence, non-specific. Dysregulated in multiple solid tumours. | None |
Cleaved high molecular weight kininogen | KNG1 |
Limited evidence Down-regulated in EC vs. Controls [69,89]. |
2 DE Electrophoresis ITRAQ technology and 2D LC–MS/MS. |
Multifunctional plasma proteins involved in the blood coagulation cascade. | Limited evidence, non-specific, high abundance plasma proteins. | None |
Tumor necrosis factor receptor 1A (TNFRSF1A) | TNFRSF1A |
Limited evidence Upregulated in EC [57]. |
Enzyme-linked immunosorbent assay (ELISA). | A ubiquitous receptor binding TNF, activating the NF-KB transcription factor, mediating apoptosis and regulating inflammation. | Limited evidence, few studies, not specific elevated in multiple sclerosis, dementia, schizophrenia etc. | None |
Colony stimulating factor 1(CSF1) | CSF1 |
Limited evidence Upregulated in EC vs. Controls [90]. |
Enzyme-linked immunosorbent assay (ELISA). | Regulatory cytokine involved in the proliferation and differentiation of haematopoietic stem cells. | Limited evidence, few studies, non-specific. | None |
Alpha fetoprotein
(AFP) |
AFP |
Limited evidence Downregulated in EC [64] |
Electrochemiluminescence | Plasma protein whose function in adult humans is less clear. Prevents transport of estradiol across placenta in rodents. | Limited evidence, non-specific, elevated in hepatic cancers germ cell tumours etc. | None |